Ge healthcare announces phase i results for a first-of-its-kind macrocyclic manganese-based mri contrast agent

Chalfont st giles, england--(business wire)--ge healthcare announces phase i results for a first-of-its-kind macrocyclic manganese-based mri contrast agent.

GEHC Ratings Summary

GEHC Quant Ranking